Latest filing published 01 Apr 2021 for Pandion Therapeutics, Inc., €3.1M.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Donald Frail appears in our data through filings on Pandion Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 21 July 2020 to 1 April 2021, the count stands at 3 filings.
On the market, this insider has only ever bought: 1 purchase, €156k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 1 April 2021 with a transaction (€3.1M) in Pandion Therapeutics, Inc. The most recent open-market purchase was published on 21 July 2020, 2,285 days ago. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations